These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Physiological changes during symptom recovery from moderate exacerbations of COPD. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Eur Respir J; 2005 Sep 31; 26(3):420-8. PubMed ID: 16135722 [Abstract] [Full Text] [Related]
17. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease. Lin YX, Xu WN, Liang LR, Pang BS, Nie XH, Zhang J, Wang H, Liu YX, Wang DQ, Xu ZY, Wang HW, Zhang HS, He ZY, Yang T, Wang C. Chin Med J (Engl); 2009 Dec 20; 122(24):2939-44. PubMed ID: 20137478 [Abstract] [Full Text] [Related]
18. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, España PP, Pérez-Izquierdo J, Aguirre U, Aizpiri S, Capelastegui A. Respir Med; 2009 Aug 20; 103(8):1201-8. PubMed ID: 19272762 [Abstract] [Full Text] [Related]
19. Relationship between depression in patients with COPD and the percent of predicted FEV(1), BODE index, and health-related quality of life. Iguchi A, Senjyu H, Hayashi Y, Kanada R, Iwai S, Honda S, Kitagawa C, Ozawa H, Rikitomi N. Respir Care; 2013 Feb 20; 58(2):334-9. PubMed ID: 22782453 [Abstract] [Full Text] [Related]
20. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD. Kuna P, Jenkins M, O'Brien CD, Fahy WA. Respir Med; 2012 Apr 20; 106(4):531-9. PubMed ID: 22197578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]